Maravai Lifesciences Holdings Inc Cash Flow-to-Debt Ratio
Maravai Lifesciences Holdings Inc cash flow-to-debt ratio. Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $3.99 Million could theoretically repay 0% of its total liabilities ($248.16 Million) in one year. Check Maravai Lifesciences Holdings Inc (MRVI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Maravai Lifesciences Holdings Inc (2018–2025)
Cash flow-to-debt ratio of Maravai Lifesciences Holdings Inc from 2018 to 2025. Historical debt coverage capacity for Maravai Lifesciences Holdings Inc across 8 annual periods. Check total reinvestment intensity of Maravai Lifesciences Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
Maravai Lifesciences Holdings Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Maravai Lifesciences Holdings Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Maravai Lifesciences Holdings Inc. For the full cash flow conversion analysis, see MRVI cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-57.57 Million | $397.87 Million | ▼ -935.5% |
| 2024 | 0.02x | $7.46 Million | $431.04 Million | ▼ -90.4% |
| 2023 | 0.18x | $126.22 Million | $697.57 Million | ▼ -53.5% |
| 2022 | 0.39x | $535.98 Million | $1.38 Billion | ▲ +45.0% |
| 2021 | 0.27x | $368.57 Million | $1.37 Billion | ▲ +96.9% |
| 2020 | 0.14x | $152.19 Million | $1.12 Billion | ▲ +145.0% |
| 2019 | 0.06x | $24.11 Million | $433.17 Million | ▲ +11822.7% |
| 2018 | 0.00x | $-186.00K | $391.66 Million | — |